⌘K
Loading ticker…
As of 2026-08-24, Sutro Biopharma, Inc. (STRO) has a 3-month relative strength percentile of 20 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 64. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.4%, relative volume 0.95×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
STRO appears in 1 ETF as of Apr 2026: PRFZ at 0.02% weight, $628K notional.
Held by 3 ETFs · $18M across latest filings · largest weight 0.02% (PRFZ).
Top 1 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PRFZ | 0.02% | $628K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | STRO Jan avg: 6.08% median: 2.76% win: 75% σ: 16.67% n: 4 2022-04-12 → 2026-07-31 | STRO Feb avg: 2.69% median: -2.03% win: 50% σ: 27.63% n: 4 2022-04-12 → 2026-07-31 | STRO Mar avg: -10.10% median: -1.51% win: 50% σ: 37.00% n: 4 2022-04-12 → 2026-07-31 | STRO Apr avg: 7.87% median: -7.79% win: 40% σ: 44.09% n: 5 2022-04-12 → 2026-07-31 | STRO May avg: -6.49% median: -14.51% win: 40% σ: 21.19% n: 5 2022-04-12 → 2026-07-31 | STRO Jun avg: -2.84% median: 3.56% win: 60% σ: 21.83% n: 5 2022-04-12 → 2026-07-31 | STRO Jul avg: 5.90% median: 12.28% win: 60% σ: 23.21% n: 5 2022-04-12 → 2026-07-31 | STRO Aug avg: 6.14% median: 6.35% win: 75% σ: 7.50% n: 4 2022-04-12 → 2026-07-31 (current) | STRO Sep avg: -12.96% median: -13.12% win: 25% σ: 14.71% n: 4 2022-04-12 → 2026-07-31 | STRO Oct avg: 8.56% median: 11.45% win: 50% σ: 26.09% n: 4 2022-04-12 → 2026-07-31 | STRO Nov avg: -9.82% median: -11.50% win: 25% σ: 10.11% n: 4 2022-04-12 → 2026-07-31 | STRO Dec avg: 16.88% median: 16.86% win: 75% σ: 39.44% n: 4 2022-04-12 → 2026-07-31 |